Skip to Content

GX LL7 (Lexiva 700 mg)

Generic Name: fosamprenavir

This pill with imprint "GX LL7" is Pink, Capsule-shape and has been identified as Lexiva 700 mg. It is supplied by GlaxoSmithKline.

Lexiva is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Lexiva 700 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for GX LL7

Lexiva 700 mg GX LL7
Lexiva 700 mg GX LL7
Lexiva 700 mg GX LL7  Front
Lexiva 700 mg GX LL7  Back

Lexiva

Generic Name:
fosamprenavir
Imprint:
GX LL7
Strength:
700 mg
Color:
Pink
Size:
21.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Protease inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
GlaxoSmithKline
Inactive Ingredients:
silicon dioxide colloidal
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
povidone k30
hypromelloses
titanium dioxide
triacetin
ferric oxide red
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide